Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used in the clinical management of hypertension and congestive heart failure. To ensure therapeutic efficacy and regulatory compliance, pharmaceutical… Read more
![Chemical structure of (2R,3aR,6aR)-1-(N-((R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-D-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R3aR6aR-1-N-R-1-Ethoxy-1-oxo-4-phenylbutan-2-yl-N-nitroso-D-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (2R,3aR,6aR)-1-(N-((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R3aR6aR-1-N-S-1-Ethoxy-1-oxo-4-phenylbutan-2-yl-N-nitroso-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)


![Chemical structure of (2S,3aR,6aR)-1-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F753405-33-3-2S3aR6aR-1-S-1-Ethoxy-1-oxo-4-phenylbutan-2-yl-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (2S,3aS,6aS)-1-(((S)-1-((1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1204213-44-4-2S3aS6aS-1-S-1-13-Dihydroxy-2-hydroxymethylpropan-2-ylamino-1-oxo-4-phenylbutan-2-yl-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Aci.png&w=3840&q=75)
![Chemical structure of (2S,3aS,6aS)-1-(N-((R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS6aS-1-N-R-1-Ethoxy-1-oxo-4-phenylbutan-2-yl-N-nitroso-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (2S,3aS,6aS)-1-(N-((S)-1-Carboxy-3-phenylpropyl)-N-nitroso-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS6aS-1-N-S-1-Carboxy-3-phenylpropyl-N-nitroso-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (2S,3aS,6aS)-1-(N-((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-D-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS6aS-1-N-S-1-Ethoxy-1-oxo-4-phenylbutan-2-yl-N-nitroso-D-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (2S,3aS,6aS)-1-(N-((S)-1-Isopropoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS6aS-1-N-S-1-Isopropoxy-1-oxo-4-phenylbutan-2-yl-N-nitroso-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (2S,3aS,6aS)-1-(N-((S)-1-Methoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS6aS-1-N-S-1-Methoxy-1-oxo-4-phenylbutan-2-yl-N-nitroso-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (2S,3aS,6aS)-1-(N-((S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-yl)-N-nitroso-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS6aS-1-N-S-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-yl-N-nitroso-L-alanyloctahydrocyclopentabpyrrole-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (S,S,S)-2-Azabicyclo[3.3.0]octane-3-carboxylic Acid, Benzyl Ester, Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F87269-87-2-SSS-2-Azabicyclo3.3.0octane-3-carboxylic-Acid-Benzyl-Ester-Hydrochloride.png&w=3840&q=75)



![Chemical structure of 2S-[(1-Carboxyethyl)amino]-benzenebutanoic Acid Methyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1356354-32-9-2S-1-Carboxyethylamino-benzenebutanoic-Acid-Methyl-Ester.png&w=3840&q=75)



![Chemical structure of Benzyl (2R,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F94498-85-8-Benzyl-2R3aS6aS-octahydrocyclopentabpyrrole-2-carboxylate.png&w=3840&q=75)
![Chemical structure of Benzyl (2S,3aR,6aR)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBenzyl-2S3aR6aR-1-S-1-ethoxy-1-oxo-4-phenylbutan-2-yl-L-alanyloctahydrocyclopentabpyrrole-2-carboxylate.png&w=3840&q=75)
![Chemical structure of Benzyl (2S,3aS,6aS)-1-nitrosooctahydrocyclopenta[b]pyrrole-2-carboxylate Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBenzyl-2S3aS6aS-1-nitrosooctahydrocyclopentabpyrrole-2-carboxylate-Hydrochloride.png&w=3840&q=75)
![Chemical structure of Benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylate, ((benzyloxy)carbonyl)-L-phenylalaninate Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F93779-32-9-Benzyl-2S3aS6aS-octahydrocyclopentabpyrrole-2-carboxylate-benzyloxycarbonyl-L-phenylalaninate-Salt.png&w=3840&q=75)
![Chemical structure of Benzyl octahydrocyclopenta[b]pyrrole-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F852547-04-7-Benzyl-octahydrocyclopentabpyrrole-2-carboxylate.png&w=3840&q=75)


![Chemical structure of Isopropyl (2S)-2-((3S,5aS,8aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)-4-phenylbutanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FIsopropyl-2S-2-3S5aS8aS-3-methyl-14-dioxodecahydro-2H-cyclopenta45pyrrolo12-apyrazin-2-yl-4-phenylbutanoate.png&w=3840&q=75)


![Chemical structure of N-[(R)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F84324-12-9-N-R-1-Ethoxycarbonyl-3-phenylpropyl-L-alanine.png&w=3840&q=75)



















Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used in the clinical management of hypertension and congestive heart failure. To ensure therapeutic efficacy and regulatory compliance, pharmaceutical laboratories require high-quality reference standards for this active ingredient, along with its associated impurities, metabolites, and stable isotope labelled compounds. These materials are essential for precise impurity profiling and the validation of analytical methods during drug development and quality control. Impurity standards facilitate the identification and quantification of process-related compounds and degradation products, while stable isotope labelled variants serve as critical internal standards for accurate mass spectrometry analysis. By utilizing these characterized substances, researchers and analysts can reliably perform method development, stability testing, and structural verification to maintain rigorous safety standards throughout the pharmaceutical lifecycle, ensuring that all testing protocols align with established quality criteria.